Animals, Humans, Ligands, Octreotide/therapeutic use, Receptors, Somatostatin/physiology, Somatostatin/adverse effects/*analogs & derivatives/metabolism
hdl.handle.net/1765/9893
European Journal of Endocrinology
Erasmus MC: University Medical Center Rotterdam

Lamberts, S.W.J, van der Lely, A-J, & Hofland, L.J. (2002). New somatostatin analogs: will they fulfil old promises?. European Journal of Endocrinology. Retrieved from http://hdl.handle.net/1765/9893